SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 4 - Statement of changes in beneficial ownership of securities:
SEC Accession No. 0001104659-24-045799
Filing Date
2024-04-10
Accepted
2024-04-10 16:06:20
Documents
1
Period of Report
2024-04-08

Document Format Files

Seq Description Document Type Size
1 OWNERSHIP DOCUMENT tm2411531-2_4seq1.html 4  
1 OWNERSHIP DOCUMENT tm2411531-2_4seq1.xml 4 4005
  Complete submission text file 0001104659-24-045799.txt   5584
Mailing Address 1185 AVENUE OF THE AMERICAS, 3RD FLOOR NEW YORK NY 10036
Business Address 1185 AVENUE OF THE AMERICAS, 3RD FLOOR NEW YORK NY 10036 9732420005
Synaptogenix, Inc. (Issuer) CIK: 0001571934 (see all company filings)

IRS No.: 461585656 | State of Incorp.: DE | Fiscal Year End: 1231
SIC: 2834 Pharmaceutical Preparations
(CF Office: 03 Life Sciences)

Mailing Address C/O ATRINSIC, INC. 1 GRAND CENTRAL PLACE SUITE 2319 NEW YORK NY 10165
Business Address
SCHECHTER JONATHAN (Reporting) CIK: 0001619259 (see all company filings)

Type: 4 | Act: 34 | File No.: 001-40458 | Film No.: 24835803